MatthewKentTophamMD
Pulmonology • Salt Lake City, UTCritical Care Medicine, Pleural Disease
Associate Professor, Internal Medicine, University of Utah School of Medicine
Are you Dr. Topham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2000 Circle of Hope Dr
Room 5363
Salt Lake City, UT 84112Phone+1 801-585-0304
Summary
- Dr. Matthew Topham, MD is a pulmonologist in Salt Lake City, Utah. He is currently licensed to practice medicine in Utah. He is affiliated with University of Utah Health and George E. Wahlen Department of Veterans Affairs Medical Center.
Education & Training
University of Utah HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1999- University of Utah HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1995
Duke University HospitalResidency, Internal Medicine, 1992 - 1994
University of Utah School of MedicineClass of 1992
Certifications & Licensure
UT State Medical License 1994 - 2024
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2007
Publications & Presentations
PubMed
- 139 citationsMammalian diacylglycerol kinases: Molecular interactions and biological functions of selected isoformsMatthew K. Topham, Richard M. Epand
Biochimica Et Biophysica Acta. 2009-06-01 - 91 citationsEffect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical TrialN. Jewel Samadder, Deborah W. Neklason, Kenneth M. Boucher, Kathryn R. Byrne, Priyanka Kanth
JAMA. 2016-03-22 - 68 citationsDiacylglycerol kinases as sources of phosphatidic acid.Jinjin Cai, Hanan Abramovici, Stephen H. Gee, Matthew K. Topham
Biochimica Et Biophysica Acta. 2009-03-02
Grant Support
- Modulation Of EGFR Signaling By Lipid Mediators In Colon CarcinogenesisNational Cancer Institute2010–2012
- Diacylglycerol Kinase Delta In Growth And DevelopmentNational Cancer Institute2002–2011
